Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)

v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)
Total
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Total The Joint Corp. stockholders' equity
Non-controlling interest
Balance, beginning common stock (in shares) at Dec. 31, 2021   14,451,355          
Balance, beginning at Dec. 31, 2021 $ 30,308,684 $ 14,450 $ 43,900,157 $ (850,838) $ (12,780,085) $ 30,283,684 $ 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2021       31,643      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 323,556   323,556     323,556  
Issuance of restricted stock (in shares)   36,722          
Issuance of restricted stock 0 $ 37 (37)     0  
Exercise of stock options (in shares)   4,972          
Exercise of stock options 49,623 $ 5 49,618     49,623  
Purchases of treasury stock under employee stock plans (in shares)       74      
Purchases of treasury stock under employee stock plans (2,598)     $ (2,598)   (2,598)  
Net income (loss) 4,220       4,220 4,220  
Balance, ending common stock (in shares) at Mar. 31, 2022   14,493,049          
Balance, ending at Mar. 31, 2022 30,683,485 $ 14,492 44,273,294 $ (853,436) (12,775,865) 30,658,485 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2022       31,717      
Balance, beginning common stock (in shares) at Dec. 31, 2021   14,451,355          
Balance, beginning at Dec. 31, 2021 30,308,684 $ 14,450 43,900,157 $ (850,838) (12,780,085) 30,283,684 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2021       31,643      
Stockholders' Equity [Roll Forward]              
Net income (loss) (136,551)            
Balance, ending common stock (in shares) at Sep. 30, 2022   14,561,545          
Balance, ending at Sep. 30, 2022 31,497,920 $ 14,561 45,231,637 $ (856,642) (12,916,636) 31,472,920 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2022       31,866      
Balance, beginning common stock (in shares) at Mar. 31, 2022   14,493,049          
Balance, beginning at Mar. 31, 2022 30,683,485 $ 14,492 44,273,294 $ (853,436) (12,775,865) 30,658,485 25,000
Balance, beginning treasury stock (in shares) at Mar. 31, 2022       31,717      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 340,191   340,191     340,191  
Issuance of restricted stock (in shares)   28,758          
Issuance of restricted stock 0 $ 29 (29)     0  
Exercise of stock options (in shares)   4,610          
Exercise of stock options 64,050 $ 5 64,045     64,050  
Net income (loss) (871,867)       (871,867) (871,867)  
Balance, ending common stock (in shares) at Jun. 30, 2022   14,526,417          
Balance, ending at Jun. 30, 2022 30,215,859 $ 14,526 44,677,501 $ (853,436) (13,647,732) 30,190,859 25,000
Balance, ending treasury stock (in shares) at Jun. 30, 2022       31,717      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 305,815   305,815     305,815  
Issuance of restricted stock (in shares)   2,845          
Issuance of restricted stock 0 $ 3 (3)     0  
Exercise of stock options (in shares)   32,283          
Exercise of stock options 248,356 $ 32 248,324     248,356  
Purchases of treasury stock under employee stock plans (in shares)       149      
Purchases of treasury stock under employee stock plans (3,206)     $ (3,206)   (3,206)  
Change in redemption value of non-controlling interest 0   0     0 0
Net income (loss) 731,096       731,096 731,096  
Balance, ending common stock (in shares) at Sep. 30, 2022   14,561,545          
Balance, ending at Sep. 30, 2022 $ 31,497,920 $ 14,561 45,231,637 $ (856,642) (12,916,636) 31,472,920 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2022       31,866      
Balance, beginning common stock (in shares) at Dec. 31, 2022 14,528,487 14,560,353          
Balance, beginning at Dec. 31, 2022 $ 32,587,843 $ 14,560 45,558,305 $ (856,642) (12,153,380) 32,562,843 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2022 31,866     31,866      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense $ 266,210   266,210     266,210  
Issuance of restricted stock (in shares)   95,386          
Issuance of restricted stock 0 $ 95 (95)     0  
Exercise of stock options (in shares)   15,621          
Exercise of stock options 138,457 $ 16 138,441     138,457  
Purchases of treasury stock under employee stock plans (in shares)       169      
Purchases of treasury stock under employee stock plans (2,637)     $ (2,637)   (2,637)  
Net income (loss) 2,326,164       2,326,164 2,326,164  
Balance, ending common stock (in shares) at Mar. 31, 2023   14,671,360          
Balance, ending at Mar. 31, 2023 $ 35,316,037 $ 14,671 45,962,861 $ (859,279) (9,827,216) 35,291,037 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2023       32,035      
Balance, beginning common stock (in shares) at Dec. 31, 2022 14,528,487 14,560,353          
Balance, beginning at Dec. 31, 2022 $ 32,587,843 $ 14,560 45,558,305 $ (856,642) (12,153,380) 32,562,843 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2022 31,866     31,866      
Stockholders' Equity [Roll Forward]              
Net income (loss) $ 1,289,402            
Balance, ending common stock (in shares) at Sep. 30, 2023 14,754,287 14,786,411          
Balance, ending at Sep. 30, 2023 $ 35,285,095 $ 14,786 46,969,761 $ (860,474) (10,863,978) 35,260,095 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2023 32,124     32,124      
Balance, beginning common stock (in shares) at Mar. 31, 2023   14,671,360          
Balance, beginning at Mar. 31, 2023 $ 35,316,037 $ 14,671 45,962,861 $ (859,279) (9,827,216) 35,291,037 25,000
Balance, beginning treasury stock (in shares) at Mar. 31, 2023       32,035      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 417,017   417,017     417,017  
Issuance of restricted stock (in shares)   91,158          
Issuance of restricted stock 0 $ 91 (91)     0  
Exercise of stock options (in shares)   10,002          
Exercise of stock options 63,929 $ 10 63,919     63,929  
Net income (loss) (320,489)       (320,489) (320,489)  
Balance, ending common stock (in shares) at Jun. 30, 2023   14,772,520          
Balance, ending at Jun. 30, 2023 35,476,494 $ 14,772 46,443,706 $ (859,279) (10,147,705) 35,451,494 25,000
Balance, ending treasury stock (in shares) at Jun. 30, 2023       32,035      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 526,069   526,069     526,069  
Issuance of restricted stock (in shares)   13,891          
Issuance of restricted stock 0 $ 14 (14)     0  
Exercise of stock options (in shares)   0          
Exercise of stock options 0 $ 0 0     0  
Purchases of treasury stock under employee stock plans (in shares)       89      
Purchases of treasury stock under employee stock plans (1,195)     $ (1,195)   (1,195)  
Net income (loss) $ (716,273)       (716,273) (716,273)  
Balance, ending common stock (in shares) at Sep. 30, 2023 14,754,287 14,786,411          
Balance, ending at Sep. 30, 2023 $ 35,285,095 $ 14,786 $ 46,969,761 $ (860,474) $ (10,863,978) $ 35,260,095 $ 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2023 32,124     32,124